Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx(R)-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma
Expert Melanoma Panel Recommends Castle Biosciences' DecisionDx(R)-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma Expert panel offers data-driven guidance for integrating DecisionDx-Melanoma into clinical decision-making for patients with melanoma GlobeNewswire December 09, 2025 FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests […]